We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCAX
1351
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$2.18M 0.01%
221,792
-17,497
-7% -$172K
KAIRW
1352
CALL
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$2.18M 0.01%
224,996
+50,000
+29% +$37K
III icon
1353
Information Services Group
III
$197M
$2.18M 0.01%
372,090
+304,043
+447% +$1.57M
PCG icon
1354
PG&E
PCG
$40.4B
$2.18M 0.01%
+213,971
New +$2.3M
IBER.WS
1355
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$2.18M 0.01%
+224,997
New +$137K
VNOM icon
1356
Viper Energy
VNOM
$8.39B
$2.17M 0.01%
115,462
+102,082
+763% +$1.83M
OHPA
1357
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
$2.17M 0.01%
+224,980
New +$2.21M
MDH.WS
1358
CALL
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$2.17M 0.01%
+225,376
New +$136K
PHI icon
1359
PLDT
PHI
$4.32B
$2.17M 0.01%
82,454
+19,222
+30% +$511K
BTMDW
1360
CALL
DELISTED
Biote Corp. Warrant
BTMDW
$2.16M 0.01%
+222,902
New +$193K
KPLTW
1361
CALL
DELISTED
Katapult Holdings Warrant
KPLTW
$2.16M 0.01%
200,000
+60,000
+43% +$201K
VICI icon
1362
VICI Properties
VICI
$30.4B
$2.15M 0.01%
69,435
-17,355
-20% -$538K
GOEVW
1363
CALL
DELISTED
Canoo Inc. Warrant
GOEVW
$2.15M 0.01%
+216,649
New +$513K
QDEL icon
1364
QuidelOrtho
QDEL
$1.16B
$2.15M 0.01%
+16,802
New +$1.98M
SLDB icon
1365
Solid Biosciences
SLDB
$756M
$2.14M 0.01%
39,062
+1,618
+4% +$107K
STRO icon
1366
Sutro Biopharma
STRO
$381M
$2.14M 0.01%
11,490
-20,554
-64% -$4.02M
AVIR icon
1367
Atea Pharmaceuticals
AVIR
$339M
$2.12M 0.01%
+98,706
New +$2.97M
LE icon
1368
Lands' End
LE
$391M
$2.12M 0.01%
51,636
+4,653
+10% +$127K
AEVAW
1369
CALL
DELISTED
Aeva Technologies Warrants
AEVAW
$2.11M 0.01%
200,000
+62,178
+45% +$181K
GIGGW
1370
CALL
DELISTED
GigCapital4, Inc. Warrant
GIGGW
$2.11M 0.01%
+214,131
New +$200K
AUS.WS
1371
CALL
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$2.11M 0.01%
+212,443
New +$308K
SOGO
1372
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$2.11M 0.01%
246,937
-240,075
-49% -$2.01M
BABA icon
1373
Alibaba
BABA
$278B
$2.1M 0.01%
9,245
-775,158
-99% -$172M
SCI icon
1374
Service Corp International
SCI
$11.8B
$2.1M 0.01%
39,085
-33,395
-46% -$1.77M
GCMGW
1375
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$2.08M 0.01%
+200,000
New +$325K

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.